Literature DB >> 20678471

Misoprostol elevates intracellular calcium in Neuro-2a cells via protein kinase A.

Javaneh Tamiji1, Dorota A Crawford.   

Abstract

Misoprostol, a prostaglandin type E analogue, has been implicated in a number of neurodevelopmental disorders. However, its mode of action in the nervous system is not well understood. Misoprostol acts on the same receptors as prostaglandin E(2) (PGE(2)), a natural lipid-derived compound, which mediates important physiological functions in the nervous system via activation of four EP receptors (EP1-4). In this study we use a ratiometric calcium imaging with fura-2 AM as a calcium indicator to show that misoprostol alters intracellular calcium levels in mouse neuroblastoma (Neuro-2a) cells via similar mechanisms as PGE(2). We demonstrate that the misoprostol-induced increase in calcium is mediated by a protein kinase A (PKA)-dependent mechanism and that the EP4 receptor signaling pathway may play an inhibitory role on calcium regulation. Overall, this study provides further support for the involvement of PGE(2) signaling in calcium homeostasis and suggests its important role in the nervous system. Crown Copyright 2010. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20678471     DOI: 10.1016/j.bbrc.2010.07.112

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Blockade of Glutamine Synthetase Enhances Inflammatory Response in Microglial Cells.

Authors:  Erika M Palmieri; Alessio Menga; Aurore Lebrun; Douglas C Hooper; D Allan Butterfield; Massimiliano Mazzone; Alessandra Castegna
Journal:  Antioxid Redox Signal       Date:  2016-11-02       Impact factor: 8.401

2.  Lack of evidence for neonatal misoprostol neurodevelopmental toxicity in C57BL6/J mice.

Authors:  Claire M Koenig; Cheryl K Walker; Lihong Qi; Isaac N Pessah; Robert F Berman
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

3.  Prostaglandin E2 alters Wnt-dependent migration and proliferation in neuroectodermal stem cells: implications for autism spectrum disorders.

Authors:  Christine T Wong; Eizaaz Ahmad; Hongyan Li; Dorota A Crawford
Journal:  Cell Commun Signal       Date:  2014-03-23       Impact factor: 5.712

4.  PGE2-EP3 signaling pathway contributes to protective effects of misoprostol on cerebral injury in APP/PS1 mice.

Authors:  Xiaoyan Tian; Chaonan Ji; Ying Luo; Yang Yang; Shengnan Kuang; Shaoshan Mai; Jie Ma; Junqing Yang
Journal:  Oncotarget       Date:  2016-05-03

5.  Maternal exposure to prostaglandin E2 modifies expression of Wnt genes in mouse brain - An autism connection.

Authors:  Ravneet Rai-Bhogal; Christine Wong; Ashby Kissoondoyal; Jennilee Davidson; Hongyan Li; Dorota A Crawford
Journal:  Biochem Biophys Rep       Date:  2018-04-10

6.  Prostaglandin E2 facilitates subcellular translocation of the EP4 receptor in neuroectodermal NE-4C stem cells.

Authors:  Jennilee M Davidson; Christine T Wong; Hongyan Li; Dorota A Crawford
Journal:  Biochem Biophys Rep       Date:  2016-06-02

7.  Prostaglandin E2 breaks down pericyte-endothelial cell interaction via EP1 and EP4-dependent downregulation of pericyte N-cadherin, connexin-43, and R-Ras.

Authors:  Carole Y Perrot; Jose L Herrera; Ashley E Fournier-Goss; Masanobu Komatsu
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.379

8.  Misoprostol Reverse Hippocampal Neuron Cyclooxygenase-2 Downstream Signaling Imbalance in Aluminum-Overload Rats.

Authors:  Yuanxin Guo; Wenjuan Lei; Jianfeng Wang; Xinyue Hu; Yuling Wei; Chaonan Ji; Junqing Yang
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  Prostaglandin E2 receptor EP4 regulates cell migration through Orai1.

Authors:  Kohei Osawa; Masanari Umemura; Rina Nakakaji; Ryo Tanaka; Rafikul Md Islam; Akane Nagasako; Takayuki Fujita; Utako Yokoyama; Toshiyuki Koizumi; Kenji Mitsudo; Yoshihiro Ishikawa
Journal:  Cancer Sci       Date:  2019-12-18       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.